RecruitingNCT04400266
Buspirone or melatonin for depression after traumatic brain injury
About this title
Read the official source — NCT04400266Medication studyAges 18–64United States
Understand this study
Who could participate?
Listed age limits: 18 years to 64 years.
- Listed locations
- Boston and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: August 1, 2020
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 10
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT04400266
- Official title
Show the full official title
Buspirone and Melatonin for Depression Following Traumatic Brain Injury
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Boston · Charlestown
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Buspirone and Mealatonin.
Who can participate?
Listed age limits: 18 years to 64 years.
Is this study still recruiting?
The registry lists this study as recruiting.
